Results 171 to 180 of about 15,165 (218)

Dual-Targeted Glucose-Dependent Insulinotropic Polypeptide-Loaded Photothermal Nanoparticles to Prevent Obesity via Lipolysis and Browning of White Adipose Tissue. [PDF]

Small Sci
Xie T, Zhao L, Pei S, Wen K, Fei S, Chen W, Li Z, Zhang L, Li L, Guo L, Huang H, Pan Q.   +11 more
europepmc   +1 more source

Decoding the impact of glucose-dependent insulinotropic polypeptide receptor (GIPR) agonist on cardiometabolic health: inflammatory mediators at the focus. [PDF]

Diabetol Metab Syndr
Cheng F, Niu X, Wang Y, Yang F, Yang K, Li W.   +5 more
europepmc   +1 more source

Comparison of Perioperative Glycemic Control in Patients Continuing Versus Temporarily Holding Glucagon-Like Peptide-1 Receptor Agonists or Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists Preoperatively. [PDF]

AACE Endocrinol Diabetes
Trykall CC, Hill SB, James AM, Bagnola AJ, Wyne KL, Handley D, Brower KI.   +6 more
europepmc   +1 more source

The physiological impact of an N-terminal Halo-tag on glucose-dependent insulinotropic polypeptide receptor function in mice. [PDF]

Diabetes Obes Metab
Davies I, Manchanda Y, Sloop KW, Bloom SR, Tan TM, Tomas A, Jones B.   +6 more
europepmc   +1 more source

Downstream interaction by glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonism is required for synergistic effects on body weight. [PDF]

Mol Metab
Feetham CH, Ai M, Culotta I, Costa A, Hunter J, Brown RA, Coskun T, Emmerson PJ, D'Agostino G, Luckman SM.   +9 more
europepmc   +1 more source

Novel Use of Glucagon-Like Peptide-1 (GLP-1) and Dual Glucose-Dependent Insulinotropic Polypeptide (GIP)/GLP-1 Receptor Agonists in Maturity-Onset Diabetes of the Young (MODY). [PDF]

Cureus
Hilal A, Afandi B, Almazrouei R.
europepmc   +1 more source

Dysfunctional Lipid-Induced Secretion of Glucagon-Like Peptide-2(GLP-2), but Not of Incretins Glucagon-Like Peptide-1(GLP-1)/Glucose-Dependent Insulinotropic Polypeptide(GIP), Promotes Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Onset and Progression Through Gut Barrier Disruption and Endotoxemia. [PDF]

MedComm (2020)
Musso G, Pinach S, Mella A, De Michieli F, Calabrese A, Trifiro D, Petrangolini G, Cassader M, Mariano F, Gambino R.   +9 more
europepmc   +1 more source

Molecular mechanisms underlying glucose-dependent insulinotropic polypeptide secretion in human duodenal organoids. [PDF]

Diabetologia
Guccio N, Alcaino C, Miedzybrodzka EL, Santos-Hernández M, Smith CA, Davison A, Bany Bakar R, Kay RG, Reimann F, Gribble FM.   +9 more
europepmc   +1 more source

The interplay of glucose-dependent insulinotropic polypeptide in adipose tissue. [PDF]

J Endocrinol
Kagdi S, Lyons SA, Beaudry JL.
europepmc   +1 more source

The Potential Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonists in Obstructive Sleep Apnea and Obesity. [PDF]

Curr Pulmonol Rep
Ellberg CC, Schwartz H, Witt A, McCowen KC, Fuentes AL, Malhotra A.   +5 more
europepmc   +1 more source